Skip to main content

Official Journal of the Italian Society of Orthopaedics and Traumatology

Table 4 Comparison between the two groups: VAS, ODI and paracetamol consumption (unpaired t test)

From: Capacitive biophysical stimulation improves the healing of vertebral fragility fractures: a prospective multicentre randomized controlled trial

 

VAS

ODI

Paracetamol consumption

Control group

CCEF group

p value

Control group

CCEF group

p value

Control group

CCEF group

p value

Baseline

(mean ± SD)

8.8 ± 0.7

8.2 ± 1.2

0.644

0.63 ± 0.04

0.625 ± 0.06

0.644

30-day follow-up

(mean ± SD)

5.2 ± 1.3

3.5 ± 0.8

0.01*

0.38 ± 0.05

0.254 ± 0.07

0.01*

0.86 ± 0.16

0.723 ± 0.14

0.033*

60-day follow-up

(mean ± SD)

2.7 ± 0.4

1.1 ± 0.3

0.02*

0.21 ± 0.04

0.127 ± 0.03

0.01*

0.544 ± 0.25

0.224 ± 0.18

0.001*

180-day follow-up

(mean ± SD)

1.02 ± 0.79

0.98 ± 0.0.88

0.544

0.11 ± 0.75

0.10 ± 0.97

0.424

0.17 ± 0.11

0.09 ± 0.07

0.001*

  1. *p < 0.005 (unpaired t test)